148 related articles for article (PubMed ID: 33901923)
1. Accuracy evaluation of the C. elegans cancer test (N-NOSE) using a new combined method.
Inaba S; Shimozono N; Yabuki H; Enomoto M; Morishita M; Hirotsu T; di Luccio E
Cancer Treat Res Commun; 2021; 27():100370. PubMed ID: 33901923
[TBL] [Abstract][Full Text] [Related]
2. [Development of an Early Cancer Detection Method Using the Olfaction of the Nematode Caenorhabditis elegans].
Uozumi T; Hirotsu T
Yakugaku Zasshi; 2019; 139(5):759-765. PubMed ID: 31061346
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of Gastrointestinal Cancer Detection by Nematode-NOSE (N-NOSE).
Kusumoto H; Tashiro K; Shimaoka S; Tsukasa K; Baba Y; Furukawa S; Furukawa J; Niihara T; Hirotsu T; Uozumi T
In Vivo; 2020; 34(1):73-80. PubMed ID: 31882465
[TBL] [Abstract][Full Text] [Related]
4. A highly accurate inclusive cancer screening test using Caenorhabditis elegans scent detection.
Hirotsu T; Sonoda H; Uozumi T; Shinden Y; Mimori K; Maehara Y; Ueda N; Hamakawa M
PLoS One; 2015; 10(3):e0118699. PubMed ID: 25760772
[TBL] [Abstract][Full Text] [Related]
5. A new detection method for canine and feline cancer using the olfactory system of nematodes.
Sugimoto T; Okuda Y; Shima A; Sugiura N; Kondo N; Ishihara G; Hirotsu T; di Luccio E
Biochem Biophys Rep; 2022 Dec; 32():101332. PubMed ID: 36111250
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1.
Attallah AM; El-Far M; Ibrahim AR; El-Desouky MA; Omran MM; Elbendary MS; Attallah KA; Qura ER; Abdallah SO
Br J Biomed Sci; 2018 Jul; 75(3):122-127. PubMed ID: 29734875
[TBL] [Abstract][Full Text] [Related]
7. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer.
He CZ; Zhang KH; Li Q; Liu XH; Hong Y; Lv NH
BMC Gastroenterol; 2013 May; 13():87. PubMed ID: 23672279
[TBL] [Abstract][Full Text] [Related]
8. Value of Combined Detection of Serum CEA, CA72-4, CA19-9, CA15-3 and CA12-5 in the Diagnosis of Gastric Cancer.
Chen C; Chen Q; Zhao Q; Liu M; Guo J
Ann Clin Lab Sci; 2017 May; 47(3):260-263. PubMed ID: 28667025
[TBL] [Abstract][Full Text] [Related]
9. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
[TBL] [Abstract][Full Text] [Related]
10. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses.
Park BJ; Cha MK; Kim IH
BMC Res Notes; 2014 Jan; 7():7. PubMed ID: 24393391
[TBL] [Abstract][Full Text] [Related]
12. [Early Diagnosis of Cancer Using Nematoda C. elegans].
Mizuguchi R; Hirotsu T
Gan To Kagaku Ryoho; 2018 Jun; 45(6):916-920. PubMed ID: 30026413
[TBL] [Abstract][Full Text] [Related]
13. Value of Combined Detection of Serum CEA, CA72-4, CA19-9 and TSGF in the Diagnosis of Gastric Cancer.
Yin LK; Sun XQ; Mou DZ
Asian Pac J Cancer Prev; 2015; 16(9):3867-70. PubMed ID: 25987051
[TBL] [Abstract][Full Text] [Related]
14. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
15. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M
Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752
[TBL] [Abstract][Full Text] [Related]
16. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
[TBL] [Abstract][Full Text] [Related]
17. The Clinical Significance of sICAM-1 in Differentiating Benign Breast Lesions from Breast Cancer.
Chen C; Chen Q; Dong Y; Liu X
Ann Clin Lab Sci; 2020 Sep; 50(5):650-656. PubMed ID: 33067211
[TBL] [Abstract][Full Text] [Related]
18. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the importance of the serum levels of CA-125, CA15-3, CA-19-9, carcinoembryonic antigen and alpha fetoprotein for distinguishing benign and malignant adnexal masses and contribution of different test combinations to diagnostic accuracy.
Bozkurt M; Yumru AE; Aral I
Eur J Gynaecol Oncol; 2013; 34(6):540-4. PubMed ID: 24601047
[TBL] [Abstract][Full Text] [Related]
20. Behavioural Response Alteration in
Kusumoto H; Tashiro K; Shimaoka S; Tsukasa K; Baba Y; Furukawa S; Furukawa J; Suenaga T; Kitazono M; Tanaka S; Niihara T; Hirotsu T; Uozumi T
Biomark Cancer; 2019; 11():1179299X19896551. PubMed ID: 31903024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
